Second Guidelines for the Diagnosis and Treatment of Vitiligo in Japan (2025)

Vitiligo is a common acquired hypopigmented disorder characterized by melanocyte damage and/or loss, primarily resulting from excessive oxidative stress and dysregulated immune responses targeting melanocytes. The initial guidelines for the diagnosis and treatment of vitiligo in Japan were published in Japanese in 2012 and in English in 2013 to provide clinical evidence for vitiligo management. Since then, there has been a substantial accumulation of pathological research and therapeutic evidence. The second guidelines for the diagnosis and treatment of vitiligo in Japan (2025) are presented as an updated resource for clinicians, incorporating worldwide expert recommendations and recent advances in basic and clinical research. These guidelines aim to provide updated knowledge for individuals with vitiligo, public health professionals, scientists, and dermatologists.

Authors

Institutions

Publication Details

Journal
The Journal of Dermatology
Published
2026-05-31
DOI
https://doi.org/10.1111/1346-8138.70313
Primary Topic
melanin and skin pigmentation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Second Guidelines for the Diagnosis and Treatment of Vitiligo in Japan (2025)

Kazuhiro Toriyama, Kenshi Yamasaki, Yuta Araki, SHINTARO INOUE et al.
The Journal of Dermatology
melanin and skin pigmentation
article

Second Guidelines for the Diagnosis and Treatment of Vitiligo in Japan (2025)

Kazuhiro Toriyama, Kenshi Yamasaki, Yuta Araki, SHINTARO INOUE, Tamihiro Kawakami, Atsushi Tanemura, Sho Hiroyasu, Yutaka Shimomura, Shigetoshi Sano, Kayoko Matsunaga, Hiroyuki Murota, Akimichi Morita, Ken Okamura, Tamio Suzuki, Naoki Oiso, Ichiro Katayama, Daisuke Tsuruta, Lingli Yang
article en

Abstract

Vitiligo is a common acquired hypopigmented disorder characterized by melanocyte damage and/or loss, primarily resulting from excessive oxidative stress and dysregulated immune responses targeting melanocytes. The initial guidelines for the diagnosis and treatment of vitiligo in Japan were published in Japanese in 2012 and in English in 2013 to provide clinical evidence for vitiligo management. Since then, there has been a substantial accumulation of pathological research and therapeutic evidence. The second guidelines for the diagnosis and treatment of vitiligo in Japan (2025) are presented as an updated resource for clinicians, incorporating worldwide expert recommendations and recent advances in basic and clinical research. These guidelines aim to provide updated knowledge for individuals with vitiligo, public health professionals, scientists, and dermatologists.

The Journal of Dermatology
Yamagata University (JP), University of Nagasaki (JP), Fujita Health University (JP), Gifu Pharmaceutical University (JP), Yamaguchi University (JP), Osaka City University (JP), Nagoya City University (JP), Nara City Hospital (JP), Tohoku Medical and Pharmaceutical University Hospital (JP), Toshima Hospital (JP), Nagasaki University (JP), Osaka Metropolitan University (JP), Tokyo Metropolitan University (JP), Kōchi University (JP), Tohoku Medical and Pharmaceutical University (JP), Kindai University (JP), The University of Osaka (JP)
Good health and well-being
Openalex Percentile: Top 8%
melanin and skin pigmentation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.